2. Academic Validation
  3. Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerization

Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerization

  • Haematologica. 2017 May;102(5):e170-e174. doi: 10.3324/haematol.2016.161570.
Julia Schanda 1,  Chun-Wei Lee 2,  Katharina Wohlan 2,  Uta Müller-Kuller 1 3,  Hana Kunkel 1,  Isabell Quagliano-Lo Coco 1 3,  Stefan Stein 1,  Alexander Metz 4,  Joachim Koch 1,  Jörn Lausen 1,  Uwe Platzbecker 5,  Hind Medyouf 1,  Holger Gohlke 4,  Michael Heuser 2,  Matthias Eder 2,  Manuel Grez 6,  Michaela Scherr 2,  Christian Wichmann 1 7
Affiliations

Affiliations

  • 1 Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany.
  • 2 Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Germany.
  • 3 German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • 4 Institute for Pharmaceutical and Medicinal Chemistry, Department of Mathematics and Natural Sciences, Heinrich Heine University Düsseldorf, Germany.
  • 5 Department of Hematology, Medical Clinic and Polyclinic I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • 6 Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany grez@gsh.uni-frankfurt.de.
  • 7 Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, Ludwig-Maximilian University Hospital, Munich, Germany.
PMID: 28154087 DOI: 10.3324/haematol.2016.161570
Figures
Products